The Aspen Aerogels Inc. (ASPN) Shares Sold by Wall Street Associates

The Aspen Aerogels Inc. (ASPN) Shares Sold by Wall Street Associates

Wall Street Associates cut its position in shares of Aspen Aerogels Inc. (NYSE:ASPN) by 53.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 274,770 shares of the company’s stock after selling 311,430 shares during the period. Wall Street Associates owned 1.34% of Aspen Aerogels worth $1,135,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. BlackRock Advisors LLC raised its stake in shares of Aspen Aerogels by 2.1% in the second quarter. BlackRock Advisors LLC now owns 81,300 shares of the company’s stock worth $404,000 after buying an additional 1,644 shares in the last quarter. TD Asset Management Inc. raised its stake in shares of Aspen Aerogels by 9.3% in the third quarter. TD Asset Management Inc. now owns 35,200 shares of the company’s stock worth $210,000 after buying an additional 3,000 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Aspen Aerogels by 0.7% in the second quarter. Vanguard Group Inc. now owns 566,095 shares of the company’s stock worth $2,813,000 after buying an additional 4,062 shares in the last quarter. Firsthand Capital Management Inc. raised its stake in shares of Aspen Aerogels by 16.7% in the second quarter. Firsthand Capital Management Inc. now owns 35,000 shares of the company’s stock worth $174,000 after buying an additional 5,000 shares in the last quarter. Finally, RBF Capital LLC raised its stake in shares of Aspen Aerogels by 14.2% in the third quarter. RBF Capital LLC now owns 41,111 shares of the company’s stock worth $245,000 after buying an additional 5,100 shares in the last quarter. 75.16% of the stock is owned by institutional investors and hedge funds.

Shares of Aspen Aerogels Inc. (NYSE:ASPN) traded down 1.58% during trading on Thursday, hitting $4.35. 29,526 shares of the stock traded hands. The firm’s market capitalization is $89.53 million. Aspen Aerogels Inc. has a 1-year low of $3.38 and a 1-year high of $6.71. The firm has a 50-day moving average of $4.18 and a 200-day moving average of $4.90.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, November 3rd. The company reported ($0.13) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by $0.04. The company earned $29.60 million during the quarter, compared to the consensus estimate of $29.05 million. Aspen Aerogels had a negative net margin of 3.64% and a negative return on equity of 3.82%. Aspen Aerogels’s revenue for the quarter was down 6.0% on a year-over-year basis. During the same period in the previous year, the company earned ($0.11) EPS. On average, equities analysts forecast that Aspen Aerogels Inc. will post ($0.44) earnings per share for the current year.

A number of analysts recently weighed in on the stock. Zacks Investment Research raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Wednesday, January 4th. Needham & Company LLC reissued a “buy” rating and issued a $8.00 price target (down previously from $9.50) on shares of Aspen Aerogels in a report on Friday, November 4th. Seaport Global Securities lowered shares of Aspen Aerogels from a “buy” rating to a “neutral” rating in a report on Friday, November 4th. Citigroup Inc. lowered shares of Aspen Aerogels from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $6.00 to $4.50 in a report on Monday, November 14th. Finally, JPMorgan Chase & Co. lowered shares of Aspen Aerogels from an “overweight” rating to a “neutral” rating in a report on Friday, November 4th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $7.50.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels Inc. (NYSE:ASPN).

Related posts

Leave a Comment